Losartan Potassium Tab — Class II drug recall D-0789-2022
Terminated recall by Preferred Pharmaceuticals, Inc., reported 2022-05-04, distributed nationwide. CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
| Recall number | D-0789-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2022-04-12 |
| Classified | 2022-04-26 |
| Reported by FDA | 2022-05-04 |
| Terminated | 2022-09-22 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp, specification failure |
| Lot numbers | E1321O, E2521H, E2621F |
| Expiration dates | 2023-05-31 |
Product
Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
Reason for recall
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0789-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.